molsidomine and sildenafil citrate

molsidomine has been researched along with sildenafil citrate in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (27.27)18.2507
2000's5 (45.45)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jonas, U; Schultheiss, D; Stief, CG; Truss, MC1
Maisch, B1
Rehse, K; Reitner, N; Scheffler, H1
Andersson, K; Fujiwara, M; Persson, K1
Kang, TM; Lee, SW1
Andersen, CU; Mulvany, MJ; Simonsen, U1
Hashitani, H; Hayase, M; Kohri, K; Sasaki, S; Suzuki, H; Yanai, Y1
Gharib, S; Gonzalez-Cadavid, NF; Kovanecz, I; Nolazco, G; Rajfer, J; Rivera, S; Segura, D; Vernet, D1
Minaz, N; Pathak, L; Razdan, R1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Reviews

1 review(s) available for molsidomine and sildenafil citrate

ArticleYear
[Pharmacological therapy in erectile dysfunction--current standards and new viewpoint].
    Wiener medizinische Wochenschrift (1946), 1997, Volume: 147, Issue:4-5

    Topics: Alprostadil; Dosage Forms; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Molsidomine; Muscle Relaxation; Muscle, Smooth; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Vasodilator Agents

1997

Other Studies

10 other study(ies) available for molsidomine and sildenafil citrate

ArticleYear
[Therapy recommendations for adverse effects of Viagra and nitrates (NO-donors)].
    Herz, 1998, Volume: 23, Issue:7

    Topics: Angina Pectoris; Blood Pressure; Contraindications; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Molsidomine; Nicorandil; Nitrates; Nitric Oxide Donors; Piperazines; Purines; Sildenafil Citrate; Sulfones

1998
Interaction of Viagra with the NO donors molsidomine and RE 2047 with regard to antithrombotic and blood pressure lowering activities.
    Archiv der Pharmazie, 1999, Volume: 332, Issue:5

    Topics: Animals; Arterioles; Blood Pressure; Drug Interactions; Fibrinolytic Agents; Hypertension; Molsidomine; Nitric Oxide Donors; Phosphodiesterase Inhibitors; Piperazines; Platelet Aggregation Inhibitors; Purines; Rats; Rats, Inbred SHR; Sildenafil Citrate; Sulfones; Sydnones; Thrombosis; Venules

1999
Nitric oxide-induced cGMP accumulation in the mouse bladder is not related to smooth muscle relaxation.
    European journal of pharmacology, 2000, Aug-04, Volume: 401, Issue:2

    Topics: Animals; Arginine; Carbachol; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Female; In Vitro Techniques; Mice; Mice, Inbred BALB C; Molsidomine; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Piperidines; Purines; Quinazolines; Sildenafil Citrate; Sulfones; Urethra; Urinary Bladder

2000
[Erectile dysfunction. Help also for cardiac patients].
    MMW Fortschritte der Medizin, 2001, Oct-11, Volume: 143, Issue:41

    Topics: Apomorphine; Contraindications; Coronary Disease; Drug Interactions; Erectile Dysfunction; Humans; Male; Molsidomine; Nitrates; Piperazines; Purines; Sildenafil Citrate; Sulfones

2001
Effects of nitric oxide on the Ca2+-activated potassium channels in smooth muscle cells of the human corpus cavernosum.
    Urological research, 2001, Volume: 29, Issue:5

    Topics: Cells, Cultured; Drug Synergism; Electric Conductivity; Electrophysiology; Humans; Male; Molsidomine; Muscle, Smooth; Nitric Oxide; Nitric Oxide Donors; Penis; Piperazines; Potassium Channels; Potassium Channels, Calcium-Activated; Purines; Sildenafil Citrate; Sulfones

2001
Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats.
    European journal of pharmacology, 2005, Mar-07, Volume: 510, Issue:1-2

    Topics: Acetylcholine; Actins; Animals; Atrial Natriuretic Factor; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Guanylate Cyclase; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Lung; Male; Molsidomine; Muscle, Smooth; Oxadiazoles; Piperazines; Pulmonary Artery; Purines; Quinoxalines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Systole; Vasodilation; Vasodilator Agents

2005
Role of nitric oxide/cyclic GMP pathway in regulating spontaneous excitations in detrusor smooth muscle of the guinea-pig bladder.
    Neurourology and urodynamics, 2008, Volume: 27, Issue:5

    Topics: Action Potentials; Animals; Calcium; Cyclic GMP; Electrophysiology; Female; Guinea Pigs; In Vitro Techniques; Indoles; Isometric Contraction; Male; Molsidomine; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Purines; Signal Transduction; Sildenafil Citrate; Sulfones; Urinary Bladder

2008
Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage.
    The journal of sexual medicine, 2012, Volume: 9, Issue:11

    Topics: Animals; Combined Modality Therapy; Impotence, Vasculogenic; Male; Mice; Molsidomine; Muscle Denervation; Muscle Fibers, Skeletal; Penile Erection; Penis; Piperazines; Purines; Rats; Rats, Inbred F344; Sildenafil Citrate; Stem Cell Transplantation; Sulfones; Vasodilator Agents

2012
Repositioning of molsidomine for its efficacy in diabetes induced erectile dysfunction in rats: In silico, in vitro and in vivo approach.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus, Experimental; Drug Repositioning; Erectile Dysfunction; Female; Male; Molsidomine; Nitric Oxide Donors; Penile Erection; Penis; Protective Agents; Rats; Rats, Wistar; Sildenafil Citrate; Streptozocin; Testosterone

2018
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013